By Brian Blase, PhD
Galen Institute, May 3, 2019

By Doug Badger Chicago Tribune, April 17, 2021 The Biden administration is launching what amounts to a federal assault against pharmaceutical innovation—innovation that led to the historic feat of producing vaccines against COVID-19 in record time. President Biden would impose federal price controls on prescription medicines that could mean up to 100 fewer drugs entering […]

By Doug Badger The Sun Sentinel, March 5, 2021 Can the federal government ban evictions? Seems like a pretty straightforward question. But the answer touches on a deeper one, as yet unsettled: Will life after COVID-19 be normal? Normal isn’t government permitting us to exercise our liberty. Normal means that we needn’t seek the government’s […]

By Brian Blase The New York Post, February 28, 2021 Democrats’ holy grail is reducing income inequality. So it’s ironic that they are considering a bill to expand ObamaCare that will primarily benefit richer households and health-insurance companies. Once again, the Democrats appear ready to unilaterally pass a law that ratchets up our already unsustainable […]

By The Editorial Board The Wall Street Journal, February 24, 2021 Progressive policy priorities are hitching a ride on Congress’s “Covid relief” bill, shoveling billions into the Affordable Care Act with the goal of making government insurance a middle-class entitlement on the way to Medicare for All. Instead of making the underlying product better or […]

By Brian Blase The Galen Institute, February 23, 2021 The Covid relief bill racing through Congress is a huge giveaway to wealthy households and health insurers, will inflate health costs and premiums, exacerbates income inequality, and sets the stage for a significant loss of employer-sponsored coverage, according to the findings in an important new paper […]

By The Health Policy Consensus Group The Heritage Foundation, February 22, 2021 Instead of addressing Obamacare’s many flaws and costly mandates, the Democrats’ misguided proposal simply throws more money at insurance companies. The economic dislocation caused by COVID-19 did not appear to have had a significant adverse effect on health insurance coverage. Congress should pursue […]

By Brian Blase The Galen Institute, February 8, 2021 In an important new paper with original findings, Galen Senior Fellow Brian Blase demonstrates that individual health insurance markets in states can be improved by the choice and competition short-term plans provide. Critics had warned that the plans would undermine the market for ACA plans and […]

February 2, 2021 As a presidential candidate, Joe Biden rejected calls from other Democrats to join them in backing a single-payer, government-run health care system, instead saying his plan was to expand and improve the Affordable Care Act. Please join the Institute for Policy Innovation and the Galen Institute for a special Zoom policy event […]

December 29, 2020 The Centers for Medicare & Medicaid Services (CMS) has taken steps to increase states’ ability to reform their individual and small group health insurance markets, and a coalition of health policy experts has provided comments supporting a proposed rule that would codify the agency’s more flexible guidance. Twenty-two health policy experts submitted […]